Clinical Trials Sponsored by Qurgen Inc.

Total 36874 results

Qurgen Inc.

Recruiting

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Solid Tumor

United States
Wugen, Inc.

Recruiting

A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States, Australia
Wugen, Inc.

Not yet recruiting

A Phase 1b Study of WU-NK-101 in Combination With Cetuximab

Squamous Cell Carcinoma of Head and Neck | Colorectal Cancer Metastatic
Wugen, Inc.

Recruiting

A Phase 1/2 Study of the Safety and Efficacy of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

Lymphoblastic Lymphoma | T-cell Acute Lymphoblastic Leukemia

United States, Australia, Netherlands, France
Wugen, Inc.

Enrolling by invitation

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

T-cell Acute Lymphoblastic Leukemia | T-cell Lymphoblastic Lymphoma

United States, Australia
QIAGEN Gaithersburg, Inc

Recruiting

Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)

SARS-CoV-2 Acute Respiratory Disease

United Kingdom
QIAGEN Gaithersburg, Inc

Not yet recruiting

QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study

Blood Disease
QIAGEN Gaithersburg, Inc

Active, not recruiting

QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study

Meningitis/Encephalitis

United Kingdom
QuesGen Systems Inc

Completed

Reversal of Cognitive Decline (ReCODE) Study (RECODE)

Alzheimer Disease | Mild Cognitive Impairment

United States
QIAGEN Gaithersburg, Inc

Withdrawn

QuantiFERON Access Clinical Performance Study Protocol

Tuberculosis (TB)
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Terminated

Clinical Evaluation of the AmniSure ROM Test

Rupture of Fetal Membranes

United States
QIAGEN Gaithersburg, Inc

Terminated

Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients

Cell-mediated Immune Response

United States
QIAGEN Gaithersburg, Inc

Completed

Collection and Extraction of Respiratory Specimens

Influenza

United States
QIAGEN Gaithersburg, Inc

Completed

QIAstat-Dx® Respiratory Panel Plus (RPP) Clinical Performance Study

Respiratory Disease

United Kingdom
QIAGEN Gaithersburg, Inc

Terminated

Clinical Evaluation of the QuantiFERON CMV Assay

CMV

United States
QIAGEN Gaithersburg, Inc

Completed

Collection and Testing of Respiratory Samples

Respiratory Syncytial Virus Infections | Influenza A | Rhinovirus | Influenza B | QIAGEN ResPlex II Advanced Panel | Infection Due to Human Parainfluenza Virus 1 | Parainfluenza Type 2 | Parainfluenza Type 3 | Parainfluenza Type 4 | Human Metapneumovirus A/B | Coxsackie Virus/Echovirus | Adenovirus Types B/C/E | Coronavirus Subtypes 229E and other conditions

United States
QIAGEN Gaithersburg, Inc

Recruiting

Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay

Respiratory Disease

United Kingdom
QIAGEN Gaithersburg, Inc

Completed

QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study

Meningitis/Encephalitis

United Kingdom
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the Artus® CMV PCR Test (CMV)

Cytomegalovirus Infections

United States
QIAGEN Gaithersburg, Inc

Terminated

Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People (QFM)

HIV Positive

United States
QIAGEN Gaithersburg, Inc
Amgen

Recruiting

Therascreen® KRAS RGQ PCR Kit

Colo-rectal Cancer

United Kingdom
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit

Non-small Cell Lung Cancer

United Kingdom
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

Colorectal Cancer | Non-Small Cell Lung Cancer

United Kingdom
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

Non Small Cell Lung Cancer

United Kingdom
Rennes University Hospital
QIAGEN Gaithersburg, Inc

Completed

cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project (KitMel)

Melanoma

France
Red Queen Therapeutics, Inc.
PPD

Completed

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

COVID-19 | Infectious Disease | SARS CoV 2 Infection | Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
Barretos Cancer Hospital
QIAGEN Gaithersburg, Inc

Completed

Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas (careHPV)

Human Papilloma Virus Infection | Prevention | Cervical Cancer Squamous Cell | Human Papilloma Virus-Related Carcinoma

Brazil
Laser Surgery Care
QIAGEN Gaithersburg, Inc

Completed

Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test

Anal Cancer | Anal Canal HPV Infection Diagnosis | Anal Dysplasia Diagnosis

United States
QuesGen Systems Inc
Cardio Surgical Partners

Recruiting

Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry (ASC ICD Reg)

Arrhythmia

United States
University Hospital, Geneva
QIAGEN Gaithersburg, Inc; Hologic, Inc.; Pregnolia AC

Completed

Prediction of Spontaneous Onset of Labor at Term (PREDICT)

Labor Onset | Labor, Induced | Labor, Obstetric | Predictive Model

Switzerland
Adhera Health, Inc.
Hospital Universitario Virgen Macarena

Completed

SENSING-AI in Patients With Long COVID (SENSING-AI) (SENSING-AI)

Post-acute COVID-19 Syndrome

Spain
Urigen

Completed

Study of U101 for Bladder Pain and/or Urgency

Pelvic Pain | Interstitial Cystitis | Bladder Diseases

United States
Urigen

Terminated

Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

Interstitial Cystitis | Bladder Pain Syndrome

United States
Qure Healthcare, LLC
Natera, Inc.

Completed

Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients (QIDNEY)

Transplant;Failure,Kidney

United States
Urigen

Completed

Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis

Interstitial Cystitis | Painful Bladder Syndrome

United States
Qure Healthcare, LLC
SomaLogic, Inc.

Completed

Clinical Utility Trial for the SomaLogic CVD-T2D Test

Cardiovascular Diseases | Type 2 Diabetes

United States
Qure Healthcare, LLC
GlycoMark, Inc

Completed

Glucose Control Using 1,5-AG Testing (GLUCAR)

Diabetes

United States
Qure Healthcare, LLC
Progenity, Inc.

Completed

Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia

Pre-Eclampsia

United States
Assistance Publique - Hôpitaux de Paris
QIAGEN Gaithersburg, Inc

Active, not recruiting

Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room (PROMCAP)

Community-acquired Pneumonia

France
Queen Mary University of London
CVRx, Inc.

Terminated

UK Registry for Baroreflex Activation Therapy (UK-BAT)

Hypertension, Resistant to Conventional Therapy | Baroreflex Failure Syndrome

United Kingdom
Washington University School of Medicine
Wugen, Inc.

Withdrawn

Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS

Myelodysplastic Syndromes | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid Leukemia
Queen Mary University of London
Metagenics, Inc.

Unknown

SPM Regulation by Fish Oil Supplements in Healthy Volunteers

Healthy Volunteers

United Kingdom
Karsten Königstein
University of Basel; QIAGEN Gaithersburg, Inc

Completed

VascuFit: Exercise and Vascular Aging (VascuFit)

Aerobic Exercise | Endothelial Function | Middle-aged Adults Sedentary, Elevated CV-risk)

Switzerland
Washington University School of Medicine
Wugen, Inc.

Recruiting

Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies

Acute Myeloid Leukemia | Sezary Syndrome | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult T Cell Leukemia | Adult T Cell Lymphoma | Hepatosplenic T-cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | T-Cell Non-Hodgkin... and other conditions

United States
Queen Margaret University
DSM Nutritional Products, Inc.

Unknown

Effects of Beta-glucan on Energy Intake and Satiety

Obesity

United Kingdom
University of Bergen
Helse-Bergen HF

Completed

Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory Hallucinations

Psychotic Disorders

Norway

Clinical Trials Sponsored by Qurgen Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations